Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000904454-17-000612
Filing Date
2017-09-14
Accepted
2017-09-14 16:33:01
Documents
1
Period of Report
2017-08-29

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 4  
1 PRIMARY DOCUMENT edgar.xml 4 4836
  Complete submission text file 0000904454-17-000612.txt   7101
Mailing Address ONE JOHNSON & JOHNSON PLZ NEW BRUNSWICK NJ 08933
Business Address ONE JOHNSON & JOHNSON PLZ NEW BRUNSWICK NJ 08933 732-524-2455
JOHNSON & JOHNSON (Reporting) CIK: 0000200406 (see all company filings)

State of Incorp.: NJ | Fiscal Year End: 0101
Type: 4 | Act: 34 | File No.: 001-36517 | Film No.: 171085967
SIC: 2834 Pharmaceutical Preparations

Mailing Address 410 GEORGE STREET NEW BRUNSWICK NJ 08901
Business Address 410 GEORGE STREET NEW BRUNSWICK NJ 08901 (732) 524-3218
Johnson & Johnson Innovation - JJDC, Inc. (Reporting) CIK: 0000924020 (see all company filings)

State of Incorp.: NJ
Type: 4 | Act: 34 | File No.: 001-36517 | Film No.: 171085966

Mailing Address 1601 TRAPELO ROAD SUITE 284 WALTHAM MA 02451
Business Address 1601 TRAPELO ROAD SUITE 284 WALTHAM MA 02451 617-600-7373
Minerva Neurosciences, Inc. (Issuer) CIK: 0001598646 (see all company filings)

EIN.: 260784194 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations